288 related articles for article (PubMed ID: 10433926)
1. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.
Keller G; Vogelsang H; Becker I; Hutter J; Ott K; Candidus S; Grundei T; Becker KF; Mueller J; Siewert JR; Höfler H
Am J Pathol; 1999 Aug; 155(2):337-42. PubMed ID: 10433926
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
3. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.
Xie ZM; Li LS; Laquet C; Penault-Llorca F; Uhrhammer N; Xie XM; Bignon YJ
Cancer; 2011 Jul; 117(14):3112-7. PubMed ID: 21271559
[TBL] [Abstract][Full Text] [Related]
4. Germline E-cadherin mutations in familial lobular breast cancer.
Masciari S; Larsson N; Senz J; Boyd N; Kaurah P; Kandel MJ; Harris LN; Pinheiro HC; Troussard A; Miron P; Tung N; Oliveira C; Collins L; Schnitt S; Garber JE; Huntsman D
J Med Genet; 2007 Nov; 44(11):726-31. PubMed ID: 17660459
[TBL] [Abstract][Full Text] [Related]
5. CDH1 germline mutations and hereditary lobular breast cancer.
Corso G; Intra M; Trentin C; Veronesi P; Galimberti V
Fam Cancer; 2016 Apr; 15(2):215-9. PubMed ID: 26759166
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
7. [Germline E-cadherin gene mutation screening in familial gastric cancer kindreds].
Jiang Y; Wan YL; Wang ZJ; Zhao B; Zhu J; Huang YT
Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):914-7. PubMed ID: 15363252
[TBL] [Abstract][Full Text] [Related]
8. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
[TBL] [Abstract][Full Text] [Related]
9. First report of a Mexican family with mutation in the CDH1 gene.
Martínez Valenzuela C; Castelán-Maldonado EE; Carvajal-Zarrabal O; Calderón-Garcidueñas AL
Mol Genet Genomic Med; 2020 Nov; 8(11):e1208. PubMed ID: 32886433
[TBL] [Abstract][Full Text] [Related]
10. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the human E-cadherin (CDH1) gene.
Berx G; Becker KF; Höfler H; van Roy F
Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
[TBL] [Abstract][Full Text] [Related]
12. Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast.
Chan JK; Wong CS
Adv Anat Pathol; 2001 May; 8(3):165-72. PubMed ID: 11345240
[No Abstract] [Full Text] [Related]
13. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN
Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
[TBL] [Abstract][Full Text] [Related]
16. Germline CDH1 mutations in bilateral lobular carcinoma in situ.
Petridis C; Shinomiya I; Kohut K; Gorman P; Caneppele M; Shah V; Troy M; Pinder SE; Hanby A; Tomlinson I; Trembath RC; Roylance R; Simpson MA; Sawyer EJ
Br J Cancer; 2014 Feb; 110(4):1053-7. PubMed ID: 24366306
[TBL] [Abstract][Full Text] [Related]
17. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.
Guilford PJ; Hopkins JB; Grady WM; Markowitz SD; Willis J; Lynch H; Rajput A; Wiesner GL; Lindor NM; Burgart LJ; Toro TT; Lee D; Limacher JM; Shaw DW; Findlay MP; Reeve AE
Hum Mutat; 1999; 14(3):249-55. PubMed ID: 10477433
[TBL] [Abstract][Full Text] [Related]
19. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
[TBL] [Abstract][Full Text] [Related]
20. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
